Jubilant Lifesciences zooms 12% on good Q4 results

NEW DELHI: Shares of Jubilant Lifesciences soared over 12 per cent to record its biggest intraday gain since January 4 in Wednesday's trade after the company reported better-than-expected fourth quarter result.

The pharmaceutical stock climbed 12.45 per cent to hit a high of Rs 762.70. At the end of the trading session the stock closed at Rs 723, up 6.6 per cent.

The company has reported a consolidated revenue at Rs 1,641 crore, up 8 per cent YoY for the quarter ended March 31.

Its profit after tax shot up 1,232 per cent to Rs 150 crore in the same period. The total sales in the same period were Rs 1,597.76 crore, up 7.61 per cent YoY.

In FY17, the company recorded its highest ever consolidated revenue at Rs 6,006 crore. The profit after tax of the company was up by 47 per cent YoY to Rs 576 crore from Rs 392 crore in FY16. Further the company reported highest ever EBTIDA at Rs 1,370 crore, up 9.7 per cent YoY.